PX1 Research provides reference-grade IGF-1 DES (Des(1-3)IGF-1) specifically synthesized for advanced cellular research and in vitro assay applications. Every batch undergoes rigorous RP-HPLC and mass spectrometry testing to guarantee structural integrity, verified purity, and strict lot-to-lot consistency.
PX1 Research provides reference-grade IGF-1 DES (Des(1-3)IGF-1) specifically synthesized for advanced cellular research and in vitro assay applications. Every batch undergoes rigorous RP-HPLC and mass spectrometry testing to guarantee structural integrity, verified purity, and strict lot-to-lot consistency.
When acquiring IGF-1 DES for laboratory research, investigators must prioritize analytical purity, lot-specific verification, and reliable domestic supply chains. PX1 Research supplies USA-manufactured IGF-1 DES engineered specifically for in vitro assays and preclinical models, verified via RP-HPLC and ESI-MS to ensure ≥98% purity alongside rigorous endotoxin screening.
Synthesized for high-precision analytical environments, our research compounds are backed by fully transparent, downloadable documentation. Principal investigators can review complete analytical profiles across our all peptides catalog, ensuring full compliance with experimental parameters and institutional procurement standards.
IGF-1 DES, truncated systematically as Des(1-3)IGF-1, is a naturally occurring splice variant and synthetic analog of human insulin-like growth factor 1. The compound consists of a 67-amino acid polypeptide chain derived by removing the tripeptide sequence Glycine-Proline-Glutamic acid (GPE) from the N-terminus of standard 70-amino acid IGF-1. This targeted structural truncation fundamentally alters its biochemical reactivity and binding dynamics in research settings.
The molecular weight of IGF-1 DES is approximately 7,372 Da, distinct from full-length native IGF-1 (7,649 Da). The removal of the N-terminal tripeptide eliminates the primary electrostatic interaction site responsible for binding to Insulin-like Growth Factor Binding Proteins (IGFBPs). In laboratory analyses, this structural variance allows researchers to study receptor activation unhindered by endogenously expressed or culture-medium binding proteins.
In cell culture models, endogenous IGFBPs act as competitive inhibitors, sequestering native IGF-1 and modulating its bioactivity. Because IGF-1 DES lacks the N-terminal sequence required for stable IGFBP complex formation, it exhibits minimal affinity for IGFBP-1 through IGFBP-6. In vitro assays demonstrate that IGF-1 DES binds to the type 1 IGF receptor (IGF-1R) with equal or slightly enhanced affinity compared to native IGF-1, but displays up to ten-fold higher relative biological potency due to its complete resistance to IGFBP neutralization.
This structural modification makes IGF-1 DES an invaluable control molecule in research investigating autocrine and paracrine signaling pathways. Preclinical assays suggest that by bypassing IGFBP sequestration, IGF-1 DES initiates rapid, intense activation of the MAPK/ERK and PI3K/Akt intracellular cascades, downstream pathways responsible for cellular proliferation, protein synthesis, and inhibition of apoptosis.
Preclinical muscle tissue models highlight IGF-1 DES as a primary reagent for investigating skeletal muscle hypertrophy and myogenesis. In vitro studies on C2C12 myoblasts show that exposure to Des(1-3)IGF-1 accelerates differentiation and fusion into mature myotubes. The absence of IGFBP binding allows for uninterrupted signaling through the PI3K/Akt/mTOR pathway, facilitating high-throughput evaluation of translational machinery upregulation.
Furthermore, animal models exploring acute focal tissue trauma indicate localized expression of endogenous IGF-1 DES following tissue stress, suggesting a biological role in rapid tissue remodeling. Laboratory evaluations using satellite cell cultures demonstrate that treatment with high-purity IGF-1 DES stimulates mitotic division and satellite cell activation, providing valuable data for cell-line expansion studies.
Understanding the distinction between truncated and extended IGF-1 analogs is essential when selecting compounds for specific experimental designs. While native IGF-1 has a short half-life due to rapid IGFBP modulation and systemic clearance, modified analogs like IGF-1 DES and IGF-1 LR3 offer altered signaling kinetics suited for distinct analytical timelines. Other growth factor mediators such as MGF act through unique mechanical damage mechanisms altogether.
IGF-1 LR3 features an N-terminal 13-amino acid extension and a substitution of Glutamic acid for Arginine at position 3, granting it a prolonged half-life (up to 20 hours in vitro) while remaining IGFBP resistant. In contrast, IGF-1 DES possesses a much shorter bio-availability window but significantly higher immediate receptor potency per unit dose. Researchers evaluating rapid signaling cascades often select IGF-1 DES, while long-term culture maintenance studies frequently utilize growth hormone secretagogues or extended-release growth factor variants.
In analytical research, peptide purity directly dictates assay reproducibility. Impurities such as truncated fragments, residual trifluoroacetic acid (TFA), or organic solvents can introduce unquantifiable variables into baseline cellular measurements. PX1 Research subjects every batch of IGF-1 DES to reverse-phase high-performance liquid chromatography (RP-HPLC) to confirm chromatographical purity of ≥98%.
Electrospray ionization mass spectrometry (ESI-MS) is simultaneously performed to verify correct monoisotopic mass and sequence identity. Laboratories ordering from PX1 Research receive full access to lot-specific Certificates of Analysis (COA), generated by independent ISO 17025 accredited testing facilities, guaranteeing absolute data integrity prior to sample integration.
Bacterial endotoxins (lipopolysaccharides) represent a major source of error in cell culture, inflammatory signaling assays, and receptor kinetics research. Standard chemical synthesis without stringent post-purification processing often leaves trace endotoxins capable of activating Toll-like receptor 4 (TLR4) in mammalian cell lines, masking target signaling effects.
Every batch of IGF-1 DES supplied by PX1 Research undergoes quantitative chromogenic Limulus Amebocyte Lysate (LAL) testing to ensure endotoxin levels remain below strictly monitored laboratory thresholds (<0.1 EU/mg). Manufactured in cGMP-compliant US facilities, our compounds are sterile-filtered and lyophilized under cleanroom standards to safeguard sensitive in vitro cultures.
Reconstitution protocols for lyophilized IGF-1 DES must account for its hydrophobic characteristics and structural susceptibility to aggregation. For optimal analytical stability, the lyophilized cake should first be dissolved in a sterile dilute acid solution, such as 10 mM to 100 mM acetic acid, to achieve complete solubilization at a primary stock concentration (e.g., 1 mg/mL).
Once fully dissolved in acidic buffer, the stock solution can be diluted into sterile phosphate-buffered saline (PBS) or cell culture media containing 0.1% BSA (Bovine Serum Albumin) as a carrier protein. The addition of a carrier protein prevents nonspecific binding of the peptide to plastic microcentrifuge tubes and culture plates during dilution series.
Lyophilized IGF-1 DES provided by PX1 Research is stable at room temperature for short periods during transit, but must be stored at -20°C or -80°C upon receipt for long-term storage. Stored in a desiccated, sub-zero environment, the un-reconstituted peptide retains structural integrity for up to 24 months without measurable degradation.
After reconstitution, stock aliquots should be divided into single-use volumes to avoid repeated freeze-thaw cycles, which induce peptide shear and aggregation. Reconstituted acidic stock solutions remain stable at 2°C to 8°C for up to one week, or at -80°C for up to 3 to 6 months when combined with appropriate protein stabilizers.
PX1 Research serves as a trusted domestic supply partner for university laboratories, biotechnology firms, and contract research organizations (CROs). Operating fulfillment facilities in California and Arizona, we provide same-day shipping on orders placed Monday through Friday before cut-off times, minimizing project downtime and supply chain friction.
Institutions requiring high-volume peptide lots for longitudinal studies or screening platforms can utilize our wholesale program. Bulk orders receive identical analytical oversight, including full lot traceability, custom synthesis options, and batch-matched COAs to support continuous, scalable research protocols.
What is the primary structural difference between IGF-1 DES and native IGF-1?
IGF-1 DES lacks the N-terminal tripeptide Glycine-Proline-Glutamic acid (GPE), reducing its total length to 67 amino acids compared to native 70-amino acid IGF-1. This truncation prevents binding to IGF Binding Proteins (IGFBPs).
Why is IGF-1 DES considered more potent in cell culture assays than standard IGF-1?
In cell culture, endogenous or serum IGFBPs bind native IGF-1 and limit its availability to the receptor. IGF-1 DES does not bind IGFBPs, allowing nearly 100% of the active peptide to interact directly with the IGF-1 receptor, resulting in higher apparent bioactivity.
How does PX1 Research verify the purity of IGF-1 DES?
Every lot undergoes independent ISO 17025 third-party testing utilizing Reverse-Phase High-Performance Liquid Chromatography (RP-HPLC) for purity assessment (≥98%) and Electrospray Ionization Mass Spectrometry (ESI-MS) to confirm molecular weight.
What is the recommended reconstitution solvent for IGF-1 DES?
For analytical reconstitution, lyophilized IGF-1 DES should initially be dissolved in sterile 10–100 mM acetic acid to establish a stable stock solution before further dilution into buffered media containing 0.1% BSA.
Are PX1 Research compounds tested for bacterial endotoxins?
Yes. Every batch of IGF-1 DES is screened via quantitative LAL assay to verify endotoxin levels are maintained below strict analytical limits (<0.1 EU/mg) to prevent artifacts in cell culture experiments.
What is the shelf life of lyophilized IGF-1 DES when stored properly?
When stored at -20°C or -80°C in a desiccated container, lyophilized IGF-1 DES maintains analytical stability and sequence integrity for up to 24 months.
How does IGF-1 DES differ from IGF-1 LR3 in laboratory applications?
IGF-1 DES features a 3-amino acid truncation and short half-life with high localized potency, making it ideal for acute signaling assays. IGF-1 LR3 features an amino acid substitution and extension, giving it a prolonged half-life (10-20 hours) suited for long-term incubation.
Can academic and corporate institutions set up bulk supply accounts for IGF-1 DES?
Yes, PX1 Research provides institutional accounts and wholesale bulk procurement options, complete with lot-matched COAs, volumetric discounts, and expedited shipping from our US fulfillment centers.
All products are sold strictly for laboratory and research use only. Not for human or veterinary use, diagnosis, treatment or consumption. Statements have not been evaluated by the FDA.